Background: The incidence rates of endometrial cancer (EC) are increasing, which may partly be explained by the rising prevalence of obesity, an established risk factor for EC. Hypertension, another component of metabolic syndrome, is also increasing in prevalence, and emerging evidence suggests that it may be associated with the development of certain cancers. The role of hypertension independent of other components of metabolic syndrome in the etiology of EC remains unclear. In this study we evaluated hypertension as an independent risk factor for EC and whether this association is modified by other established risk factors. Methods: We included 15,631 EC cases and 42,239 controls matched on age, race, and study-specific factors from 29 studies in the Epidemiology of Endometrial Cancer Consortium. We used multivariable unconditional logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals (CIs) to evaluate the association between hypertension and EC and whether this association differed by study design, race/ethnicity, body mass index, diabetes status, smoking status, or reproductive factors. Results: Hypertension was associated with an increased risk of EC (OR=1.14, 95% CI:1.09-1.19). There was significant heterogeneity by study design (Phet<0.01), with a stronger magnitude of association observed among case-control vs. cohort studies. Stronger associations were also noted for pre-/peri-menopausal women and never users of postmenopausal hormone therapy. Conclusions: Hypertension is associated with EC risk independently from known risk factors. Future research should focus on biologic mechanisms underlying this association. Impact: This study provides evidence that hypertension may be an independent risk factor for EC.
Hypertension and risk of endometrial cancer: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2) / T.S. Habeshian, N.C. Peeri, I. De Vivo, L.J. Schouten, X. Shu, M.L. Cote, K.A. Bertrand, Y. Chen, M.A. Clarke, T.V. Clendenen, L.S. Cook, L. Costas, L. Dal Maso, J.L. Freudenheim, C.M. Friedenreich, G. Gallagher, G.L. Gierach, M.T. Goodman, S.J. Jordan, C. La Vecchia, J.V. Lacey, F. Levi, L.M. Liao, L. Lipworth, L. Lu, X. Matías-Guiu, K.B. Moysich, G.L. Mutter, R. Na, J. Naduparambil, E. Negri, K. O'Connell, T.A. O'Mara, I. Onieva Hernández, J.R. Palmer, F. Parazzini, A.V. Patel, K.L. Penney, A.E. Prizment, F. Ricceri, H.A. Risch, C. Sacerdote, S. Sandin, R.Z. Stolzenberg-Solomon, P.A. van den Brandt, P.M. Webb, N. Wentzensen, A.T. Wijayabahu, L.R. Wilkens, W. Xu, H. Yu, A. Zeleniuch-Jacquotte, W. Zheng, M. Du, V.W. Setiawan. - In: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. - ISSN 1055-9965. - 33:6(2024 Jun 03), pp. 788-795. [10.1158/1055-9965.EPI-23-1444]
Hypertension and risk of endometrial cancer: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
C. La Vecchia;E. Negri;F. Parazzini;
2024
Abstract
Background: The incidence rates of endometrial cancer (EC) are increasing, which may partly be explained by the rising prevalence of obesity, an established risk factor for EC. Hypertension, another component of metabolic syndrome, is also increasing in prevalence, and emerging evidence suggests that it may be associated with the development of certain cancers. The role of hypertension independent of other components of metabolic syndrome in the etiology of EC remains unclear. In this study we evaluated hypertension as an independent risk factor for EC and whether this association is modified by other established risk factors. Methods: We included 15,631 EC cases and 42,239 controls matched on age, race, and study-specific factors from 29 studies in the Epidemiology of Endometrial Cancer Consortium. We used multivariable unconditional logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals (CIs) to evaluate the association between hypertension and EC and whether this association differed by study design, race/ethnicity, body mass index, diabetes status, smoking status, or reproductive factors. Results: Hypertension was associated with an increased risk of EC (OR=1.14, 95% CI:1.09-1.19). There was significant heterogeneity by study design (Phet<0.01), with a stronger magnitude of association observed among case-control vs. cohort studies. Stronger associations were also noted for pre-/peri-menopausal women and never users of postmenopausal hormone therapy. Conclusions: Hypertension is associated with EC risk independently from known risk factors. Future research should focus on biologic mechanisms underlying this association. Impact: This study provides evidence that hypertension may be an independent risk factor for EC.
hypertension; endometrail cancer risk; E2C2;
Settore MED/01 - Statistica Medica
Settore MED/06 - Oncologia Medica
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
Settore MED/40 - Ginecologia e Ostetricia
Settore MED/42 - Igiene Generale e Applicata
3-giu-2024
26-mar-2024
Article (author)
01 - Articolo su periodico
{% } %}
{%# o.licenseName %}
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
| EPI-23-1444 788..795 - Hypertension E2C2.pdf accesso aperto Tipologia:Publisher's version/PDF Dimensione183.16 kB FormatoAdobe PDF Visualizza/Apri | 183.16 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
